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To determine susceptibility of chickens, turkeys, and 
mice to pandemic (H1N1) 2009 virus, we conducted contact 
exposure and inoculation experiments. We demonstrated 
that chickens were refractory to infection. However, oculo-
oronasally inoculated turkeys and intranasally inoculated 
mice seroconverted without clinical signs of infection.
T
he current outbreak of pandemic (H1N1) 2009 contin-
ues to expand in humans, with occasional spillover into 
domestic pigs. Pandemic (H1N1) 2009 virus causes only 
mild disease compared with pandemic inﬂ  uenza viruses 
from the 20th century. However, this characteristic might 
change if pandemic (H1N1) 2009 viruses acquire virulence 
markers by reassorting with inﬂ  uenza viruses that cause se-
vere disease in humans, such as highly pathogenic avian 
inﬂ  uenza viruses (HPAIVs) of the H5N1 subtype. Such re-
assortment might occur in humans but appears more likely 
in so-called mixing vessels. Pigs, which had been described 
as potential mixing vessels (1), are highly susceptible to 
infection with pandemic (H1N1) 2009 virus (2,3). In ad-
dition, pigs have been infected subclinically by HPAIV 
(H5N1) in countries to which HPAIV (H5N1) is endemic 
(4). However, whether poultry can be infected with pan-
demic (H1N1) 2009 virus is not well understood. There-
fore, we determined the susceptibility of chickens, turkeys, 
and mice to pandemic (H1N1) 2009 virus.
The Study
All animal experiments were reviewed and approved 
by the responsible state ethics committee (LALLF M-V/
TSD/7221.3–2.1.-014/09). Five chickens (12 weeks of age, 
speciﬁ  c pathogen–free [spf]) were inoculated oculo-orona-
sally by dripping a 106 50% tissue culture infectious dose 
(TCID50) of virus A/Regensburg/D6/09/H1N1 on the cor-
nea, nares, and oropharynx. Ten chickens (3 months of age, 
spf) were inoculated intravenously with 104 TCID50. Five 
chickens (15 weeks of age, spf) were housed (permanent 
contact behind bars and daily direct contact for 30 min) 
with pigs infected with pandemic (H1N1) 2009 virus (3).
A second transmission experiment was performed 
with the same contact exposure experimental setup, which 
included 8 infected pigs and 5 turkeys (4 weeks of age). 
In addition, 28 chickens (1 week of age) and 28 turkeys (1 
week of age) were inoculated with 200 μL of virus suspen-
sion (106 TCID50) directly into the left air sac. Six fattening 
turkeys (16 weeks of age) from a local ﬂ  ock were inocu-
lated oculo-oronasally with 106 TCID50 of A/Regensburg/
D6/09 (H1N1) virus. Six fattening turkeys were inoculated 
oculo-oronasally with 108 TCID50 of the more recently 
isolated pandemic (H1N1) 2009 A/Bayern/74/2009 virus. 
Cloacal and oropharyngeal swab samples from poultry in-
fected oculo-oronasally, through the air sac, or by contact 
with pigs were collected daily. Samples were tested by 
using a real-time reverse transcription–PCR with subtype 
H1N1–speciﬁ  c primers (http://ofﬂ  u.net) (Table).
Additional studies were conducted to determine the 
50% lethal dose of strain A/Regensburg/D6/2009 pan-
demic (H1N1) 2009 virus for mice. Sixteen BALB/c mice 
(6 weeks of age) were inoculated intranasally with 102–105 
TCID50/animal (30 μL), and 4 mice were inoculated intrap-
eritoneally with 105 TCID50/animal (30 μL).
None of the inoculated animals became ill after infec-
tion by any tested route; the intravenous pathogenicity in-
dex of the virus for chickens was 0. All swab samples from 
poultry after contact with infected pigs or from poultry in-
oculated through the air sac were negative for virus (Table). 
Virus excretion by pigs was detected (3); real-time reverse 
transcription–PCR cycle threshold values >26 (contact ex-
periment with chickens) or >17 (contact experiment with 
turkeys). Virus RNA was detected (cycle threshold values 
27–39) in swab samples obtained 1–6 days postinoculation 
from the oropharynx of turkeys inoculated with 108 TCID50 
of the A/Bayern/74/2009 (H1N1) strain. Small amounts of 
virus RNA also were detected in the lung and left air sac 
from a few chicks and poults early after infection through 
the air sac (Table), which most likely represent residual in-
oculum. Although contact exposure pigs were infected (3), 
seroconversion was not detected in any of the tested contact 
exposure poultry species. Poultry inoculated intravenously 
or through the air sac and chickens inoculated oculo-orona-
sally were negative for antibodies against inﬂ  uenza A virus 
nucleoprotein.
Fattening turkeys seroconverted after oculo-oronasal 
inoculation with 106 TCID50 or 108 TCID50 (Table). In addi-
tion, 7 of 8 mice inoculated with 104 TCID50 or 105 TCID50 
by the oculo-oronasal route seroconverted; 4 mice inocu-
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Conclusions
Our results demonstrate lack of susceptibility of chick-
ens and minor susceptibility of turkeys for infection by 
pandemic (H1N1) 2009 virus. Transmission of swine in-
ﬂ  uenza viruses to poultry, particularly to turkeys, has been 
demonstrated (5), and experimental infection of chickens 
with virus subtype H3N2 resulted in a low replication rate, 
primarily in the alimentary tract (6). In contrast, our data 
indicate that pandemic (H1N1) 2009 virus cannot produc-
tively infect chickens at the ages of 1 week (air sac inocula-
tion), 12 weeks (contact exposure, intravenous inoculation), 
or 15 weeks (oculo-oronasal inoculation), or turkeys at the 
ages of 1 week (air-sac inoculation) and 4 weeks (contact 
exposure) because neither virus excretion nor seroconver-
sion was observed during the 10-day observation period. 
Fattening turkeys from a local ﬂ  ock seroconverted after 
oculo-oronasal inoculation, but virus RNA was detected in 
respiratory samples only in turkeys inoculated with a high 
dose of the A/Bayern/74/2009 (H1N1) virus (Table).
On the basis of our experiments, risk for transmission 
of pandemic (H1N1) 2009 virus strain to chicken and tur-
keys and subsequent possible reassortment with other avian 
inﬂ  uenza viruses should be low. However, we observed a 
slightly higher susceptibility of older turkeys to high doses 
of pandemic (H1N1) 2009 virus, which is consistent with 
recent reports of infected layer turkey ﬂ  ocks in Chile and 
Canada (7,8). Analysis of speciﬁ  c virus strains involved 
in these outbreaks would be useful for conﬁ  rming these 
observations and analyzing different strains. Host factors 
(age, physiologic state, stress levels, and concurrent infec-
tions) inﬂ  uencing susceptibility of turkeys should be inves-
tigated. Our data, which demonstrate absence of illness in 
poultry after inoculation with pandemic (H1N1) 2009 vi-
rus, are consistent with those of recent experimental infec-
tions of poultry, including turkeys (9–11). Seroconversion 
was detected only in turkeys by using a hemagglutination-
inhibition test in 1 study (9), which might indicate higher 
sensitivity of competitive ELISAs used in our study.
As in other studies (12,13), characterization of pan-
demic (H1N1) 2009 virus strains in BALB/c mice showed 
differences in lethal dose and clinical signs dependent on 
the virus strain. None of the infected BALB/c mice in our 
study showed clinical signs. These ﬁ  ndings may have re-
sulted from the fact that mice were infected intranasally 
without anesthesia and with a dose <106 TCID50/animal or 
because of a different phenotype of the virus strain used. 
However, replication competence of pandemic (H1N1) 
2009 virus in mice without prior adaptation was indicated 
by seroconversion, at least for the higher infectious doses 
(Table). Intraperitoneal inoculation did not cause develop-
ment of inﬂ  uenza virus–speciﬁ  c antibodies. This ﬁ  nding 
cannot be explained by receptor speciﬁ  city of pandemic 
(H1N1) 2009 virus because Childs et al. (14) showed that 
representative pandemic (H1N1) 2009 viruses bound not 
only to most α2–6-linked sialyl moieties, irrespective of the 
backbone chain length and type, but also to a considerable 
range of α2–3-linked sialyl residues. Although virus rep-
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Table. Susceptibility of chicken, turkeys, and mice to pandemic (H1N1) 2009 virus* 
Animal and dose (virus 
strain) 
No.
animals Route of inoculation  Swab samples
Tissue samples,  
no. positive/no. tested† 
Seroconversion
in NP-ELISA
(no. positive/no. tested)‡ 
Chicken 5 Oculo-oronasal – NA –
Chick 28 Intra–air sac  – Day 2: 2/3; Day 4: 2/3; 
Day  8: 1/3 
–
Chicken 10 Intravenous NA NA –
Chicken 5 Contact with infected pigs  – NA –
Turkey, 10
6 TCID50
(A/Regensburg/D6/2009) 
6 Oculo-oronasal – NA +  (3/6) 
Turkey, 10
8 TCID50
(A/Bayern/74/2009) 
6 Oculo-oronasal +  (respiratory), 
– (cloacal) 
NA + (4/6) 
Poult 28 Intra–air sac  – Day 2: 3/3; Day 4: 1/3; 
Day 6: 1/3 
–
Turkey  5 Contact with infected pigs  – NA –
Mouse, 10
2–10
3 TCID50 8 Oculo-oronasal NA NA –
Mouse, 10
4 TCID50 4 Oculo-oronasal NA NA + (3/4) 
Mouse, 10
5 TCID50 4 Oculo-oronasal NA NA + (4/4) 
Mouse, 10
5 TCID50 4 Intraperitoneal NA NA –
*NP, nucleoprotein; –, negative; NA, not applicable; +, positive; TCID50, 50% tissue culture infectious dose. 
†Three juvenile chickens and turkeys inoculated through the air sac were killed on days 0, 2, 4, 6, 8, and 14 posinoculation, and left and right lung lobes 
were removed for analysis by real-time reverse transcription–PCR. Tissues from the left (inoculation site) lung lobe of 5 chicks and 4 poults killed at the 
indicated days postinfection were positive for virus RNA with high cycle threshold values (>35), and 1 additional poult was positive for virus RNA with a 
cycle threshold value of 27 on day 2 postinfection. 
‡Seroconversion was verified by testing for antibodies against virus NP by commercially available ELISAs (ELISA Avian Influenza Type A; Pourquier, 
Montpellier, France, and FlockChek AI MultiS-Screen; IDEXX, Ludwigsburg, Germany). Limited Susceptibility to Pandemic (H1N1) 2009 Virus
lication may be reduced after intraperitoneal inoculation, 
development of neutralizing antibodies after inoculation by 
this route has been reported (15).
Our results demonstrate lack of susceptibility and ab-
sence of serologic responses of chickens and turkeys to 
contact infection with an early human-origin isolate of pan-
demic (H1N1) 2009 virus. However, direct inoculation of 
fattening turkeys resulted in seroconversion and detection 
of virus RNA in oropharyngeal swab samples. Generation 
of new variants and reassortants caused by double infec-
tions with other inﬂ  uenza A viruses and pandemic (H1N1) 
2009 virus in poultry other than turkeys appears unlikely. 
However, further adaptation of pandemic (H1N1) virus 
strains in turkeys cannot be excluded.
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